TCM
BSX icon

Twin Capital Management’s Boston Scientific BSX Stock Holding History

Twin Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.1M Sell
33,420
-1,188
-3% -$95K 0.27% 98
2025
Q4 		$3.3M Buy
34,608
+307
+0.9% +$30.1K 0.41% 63
2025
Q3 		$3.35M Sell
34,301
-7,227
-17% -$748K 0.42% 59
2025
Q2 		$4.46M Buy
41,528
+865
+2% +$87.5K 0.47% 49
2025
Q1 		$4.1M Buy
40,663
+20,229
+99% +$2.04M 0.48% 54
2024
Q4 		$1.83M Sell
20,434
-156
-0.8% -$13.7K 0.2% 126
2024
Q3 		$1.73M Sell
20,590
-136
-0.7% -$10.7K 0.19% 139
2024
Q2 		$1.6M Buy
20,726
+214
+1% +$15.7K 0.19% 138
2024
Q1 		$1.4M Sell
20,512
-2,484
-11% -$160K 0.17% 148
2023
Q4 		$1.33M Buy
22,996
+1,816
+9% +$96.9K 0.17% 152
2023
Q3 		$1.12M Buy
+21,180
New +$1.11M 0.16% 158
2016
Q2 		– Sell
-128,410
Closed -$2.42M – 346
2016
Q1 		$2.42M Buy
128,410
+10,870
+9% +$191K 0.19% 156
2015
Q4 		$2.17M Buy
+117,540
New +$2.11M 0.18% 158
2013
Q3 		– Sell
-48,700
Closed -$451K – 317
2013
Q2 		$451K Buy
+48,700
New +$413K 0.05% 291

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Twin Capital Management's BSX Position: Q1 2026 in Review

Twin Capital Management reduced its Boston Scientific (BSX) stake by 3.4% in Q1 2026, selling an estimated $95K and leaving 33,420 shares worth $2.1M. The position accounts for 0.27% of the portfolio, ranked #98.

Twin Capital Management first reported a position in BSX in Q2 2013 and has held it in 14 quarters since. The position peaked at $4.46M in Q2 2025. 1,665 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Twin Capital Management held 33,420 shares of Boston Scientific worth $2.1M as of Q1 2026.
  • Twin Capital Management sold 1,188 Boston Scientific shares in Q1 2026, an estimated $95K.
  • Boston Scientific made up 0.27% of Twin Capital Management's portfolio in Q1 2026, its #98 holding.
  • Twin Capital Management first reported a position in Boston Scientific in Q2 2013 and has held it in 14 quarters since.
  • Twin Capital Management's Boston Scientific position peaked at $4.46M in Q2 2025.
  • 1,665 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Twin Capital Management's 13F filing for Q1 2026, filed 5 May 2026.